Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours May 8, 2024 Novartis announced today that the National Institute for Health and Care Excellence has published its Final Draft…
Cancer Drug News A closed-loop drug-delivery system could improve chemotherapy May 3, 2024 When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the…
Cancer Drug News FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer May 2, 2024 On April 18, 2024, the Food and Drug Administration approved alectinib for adjuvant treatment following…
Cancer Drug News FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer May 1, 2024 The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, to be…
Cancer Drug News Assessment of clinical benefit in recent FDA accelerated approvals for cancer drugs April 12, 2024 The process of accelerated approval by the US Food and Drug Administration (FDA) has been…
Cancer Drug News Colorectal cancer gene implicated in broad range of solid tumours April 4, 2024 A gene associated with colorectal cancer appears to also play a role in the development…
Cancer Drug News FDA approves mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer April 4, 2024 On March 22, 2024, the Food and Drug Administration approved mirvetuximab soravtansine-gynx for adult patients…
Cancer Drug News FDA grants accelerated approval to ponatinib with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia March 30, 2024 On March 19, 2024, the Food and Drug Administration granted accelerated approval to ponatinib (Iclusig,…
Cancer Drug News Relugolix results for prostate cancer treatment with radiation therapy March 16, 2024 A high impact study led by Daniel Spratt, M.D., University Hospitals Seidman Cancer Center, USA,…
Cancer Drug News FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications March 16, 2024 On March 1, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…